Ryan Reed to Compete in the Drive to Stop Diabetes 300 presented by Lilly Diabetes

Ryan Reed to Compete in the Drive to Stop Diabetes 300 presented by Lilly Diabetes

Ryan Reed will compete in this Saturday’s (March 15th) Drive to Stop Diabetes 300 race at Bristol Motor Speedway (BMS).  This marks the second NASCAR Nationwide Series (NNS) start at this track for him.  Reed will be driving the No. 16 American Diabetes Association Drive to Stop Diabetes℠  presented by Lilly Diabetes Ford Mustang.  In his other start at the .53-mile oval in the fall of 2013, Reed started 27th and finished 26th.

If you’re lucky enough to live in the Bristol, Tennessee, area or go to the race, Drive to Stop Diabetes℠  (D2SD) will host an activation space in the fan midway at BMS. The display area features the No. 16 D2SD racing simulator, diabetes awareness and educational materials as well as various prizes. The display is open March 15 (8:00 a.m. – 1:30 p.m.) and March 16 (8:00 a.m. – 1:00 p.m.).   Reed will also appear for a Q&A at the Drive to Stop Diabetes℠ display on Saturday, March 15 from 9:20 – 9:35 a.m.

Reed on racing at Bristol Motor Speedway:

“Bristol was probably the toughest race track for me that I went to last year. I was able to learn a ton and I think having that experience will help us get our first top-10 of the season. I am so excited that  Drive to Stop Diabetes℠ is going to go get so much exposure this weekend, and I can’t thank Lilly Diabetes enough for making that happen.”

About the American Diabetes Association: 

The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes.

About Lilly Diabetes

Lilly has been a global leader in diabetes care since 1923, when they introduced the world’s first commercial insulin. Today they are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—they strive to make life better for all those affected by diabetes around the world.

Source: Drive to Stop Diabetes℠

 

7ads6x98y